Type-specific incidence and persistence of HPV infection among young women: A prospective study in north India

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 3, 2012, Pages 1019-1024

  Datta, Palika ^a   Bhatla, Neerja ^a   Pandey, R M ^a   Dar, Lalit ^a   Patro, A Rajkumar ^a   Vasisht, Shachi ^a   Kriplani, Alka ^a   Singh, Neeta ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acquisition; Human papillomavirus; North India; Persistence

Indexed keywords

VIRUS DNA;

ALPHAPAPILLOMAVIRUS; ARTICLE; CLASSIFICATION; FEMALE; GENETICS; GENOTYPE; HUMAN; INCIDENCE; INDIA; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PROSPECTIVE STUDY; UTERINE CERVIX; VAGINA SMEAR; VIROLOGY;

ALPHAPAPILLOMAVIRUS; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; INCIDENCE; INDIA; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; VAGINAL SMEARS;

EID: 84871678883     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.3.1019     Document Type: Article

References (21)

1. Ahdieh L, Klein RS, Burk R, et al (2001). Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis, 184, 682-90.
2. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 54, 244-5
3. Brown DR, Shew ML, Qadadri B, et al (2005). A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis, 191, 182-2.
4. Castle PE, Schiffman M, Herrero R, et al (2005). A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis, 191, 1808-6.
5. Datta P, Bhatla N, Dar L, et al (2010). Prevalence of human papillomavirus infection among young women in North India. Cancer Epidemiol, 34, 157-1.
6. Franco EL, Villa LL, Sobrinho JP, et al (1999). Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis, 180, 1415-3.
7. Giuliano AR, Harris R, Sedjo RL, et al (2002). Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women's Health Study. J Infect Dis, 186, 462-9.
8. Goodman MT, Shvetsov YB, McDuffie K, et al (2008). Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res, 168, 8813-4.
9. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD (1998). Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med, 338, 423-8.
10. Molano M, Van Den Brule A, Plummer M, et al (2003). Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol, 158, 486-4.
11. Moscicki AB, Hills N, Shiboski S, et al (2001). Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA, 285, 2995-1.
12. Moscicki AB, Schiffman M, Kjaer S, Villa LL (2006). Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine, 24, 42-1.
13. Moscicki AB, Shiboski S, Broering J, et al (1998). The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatrics, 132, 277-4.
14. Muñoz N, Méndez F, Posso H, et al (2004). Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis, 190, 2077-7.
15. Richardson H, Kelsall G, Tellier P, et al (2003). The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev, 12, 485-0.
16. Sellors JW, Karwalajtys TL, Kaczorowski J, et al (2003). Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ, 168, 421-5.
17. Trottier H, Mahmud S, Prado JC, et al (2008). Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis, 197, 1436-7.
18. Walboomers JM, Jacobs MU, Manos MM, et al (1999). HPV is necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
19. Winer RL, Lee SK, Hughes JP, et al (2003). Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol, 157, 218-6.
20. Woodman CB, Collins S, Winter H, et al (2001). Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet, 357, 1831-6.
21. Zur Hausen H (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer, 2, 342-50.